[Atrial natriuretic factor in liver cirrhosis. Relation to hemodynamic parameters]. 1990

V Tesar, and K Horký, and J Jedlicka, and J Petrtýl, and J Kopecká, and I Gregorová, and Z Marecek, and F Perlík, and V Kordac
I. interní katedra fakulty vseobecného lékarství, Praha.

In 12 patients with cirrhosis of the liver (six with ascites) and six controls the authors made catheterizations of the hepatic veins and portal circulation, assessing concurrently the in cardiac output by thermodilution. The patients with ascitic cirrhosis had, as compared with controls, a significantly higher portohepatic gradient, central venous pressure, mean pressure in the pulmonary artery and also pulmonary capillary wedged pressure and a significantly lower mean arterial pressure and systemic vascular resistance. These patients had also, as compared with controls, a significantly higher concentration of ANF (atrial natriuretic factor) in the pulmonary artery (15.89 +/- 2.26 vs. 8.04 +/- 0.97, p less than 0.01) and in the hepatic vein (7.44 +/- 0.44 vs. 3.91 +/- 0.63, p less than 0.01); the difference between ANF concentrations in the peripheral blood stream was not significant (9.52 +/- 2.46 vs. 5.71 +/- 1.24 n. s.). Patients with ascitic cirrhosis of the liver had a significantly higher calculated cardiac production of ANF than controls (24.36 +/- 3.44 vs. 8.12 +/- 2.9, p less than 0.01); the difference in the splanchnic extraction of ANF between patients with ascitic cirrhosis of the liver (0.46 +/- 0.1) and controls (0.51 +/- 0.06) was not significant. The ANF concentration in the pulmonary artery in patients with cirrhosis of the liver correlated significantly with the central venous pressure (r = 0.677, p = 0.02) and the pressure in the pulmonary artery in a wedged position (r = 0.639, p = 0.03).(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D008103 Liver Cirrhosis Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. Cirrhosis, Liver,Fibrosis, Liver,Hepatic Cirrhosis,Liver Fibrosis,Cirrhosis, Hepatic
D008297 Male Males
D009320 Atrial Natriuretic Factor A potent natriuretic and vasodilatory peptide or mixture of different-sized low molecular weight PEPTIDES derived from a common precursor and secreted mainly by the HEART ATRIUM. All these peptides share a sequence of about 20 AMINO ACIDS. ANF,ANP,Atrial Natriuretic Peptide,Atrial Natriuretic Peptides,Atriopeptins,Auriculin,Natriuretic Peptides, Atrial,ANF (1-126),ANF (1-28),ANF (99-126),ANF Precursors,ANP (1-126),ANP (1-28),ANP Prohormone (99-126),ANP-(99-126),Atrial Natriuretic Factor (1-126),Atrial Natriuretic Factor (1-28),Atrial Natriuretic Factor (99-126),Atrial Natriuretic Factor Precursors,Atrial Natriuretic Factor Prohormone,Atrial Natriuretic Peptide (1-126),Atrial Pronatriodilatin,Atriopeptigen,Atriopeptin (1-28),Atriopeptin (99-126),Atriopeptin 126,Atriopeptin Prohormone (1-126),Cardiodilatin (99-126),Cardiodilatin Precursor,Cardionatrin I,Cardionatrin IV,Prepro-ANP,Prepro-CDD-ANF,Prepro-Cardiodilatin-Atrial Natriuretic Factor,Pro-ANF,ProANF,Proatrial Natriuretic Factor,Pronatriodilatin,alpha ANP,alpha-ANP Dimer,alpha-Atrial Natriuretic Peptide,beta-ANP,beta-Atrial Natriuretic Peptide,gamma ANP (99-126),gamma-Atrial Natriuretic Peptide,Natriuretic Peptide, Atrial,Peptide, Atrial Natriuretic,Peptides, Atrial Natriuretic,Prepro ANP,Prepro CDD ANF,Prepro Cardiodilatin Atrial Natriuretic Factor,Pro ANF,alpha ANP Dimer,alpha Atrial Natriuretic Peptide,beta ANP,beta Atrial Natriuretic Peptide,gamma Atrial Natriuretic Peptide
D005260 Female Females
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

V Tesar, and K Horký, and J Jedlicka, and J Petrtýl, and J Kopecká, and I Gregorová, and Z Marecek, and F Perlík, and V Kordac
January 1989, Annales francaises d'anesthesie et de reanimation,
V Tesar, and K Horký, and J Jedlicka, and J Petrtýl, and J Kopecká, and I Gregorová, and Z Marecek, and F Perlík, and V Kordac
October 1991, The Journal of thoracic and cardiovascular surgery,
V Tesar, and K Horký, and J Jedlicka, and J Petrtýl, and J Kopecká, and I Gregorová, and Z Marecek, and F Perlík, and V Kordac
July 1988, Archives des maladies du coeur et des vaisseaux,
V Tesar, and K Horký, and J Jedlicka, and J Petrtýl, and J Kopecká, and I Gregorová, and Z Marecek, and F Perlík, and V Kordac
August 1994, Journal of hepatology,
V Tesar, and K Horký, and J Jedlicka, and J Petrtýl, and J Kopecká, and I Gregorová, and Z Marecek, and F Perlík, and V Kordac
January 1987, Acta medica Austriaca,
V Tesar, and K Horký, and J Jedlicka, and J Petrtýl, and J Kopecká, and I Gregorová, and Z Marecek, and F Perlík, and V Kordac
October 1988, Gastroenterologie clinique et biologique,
V Tesar, and K Horký, and J Jedlicka, and J Petrtýl, and J Kopecká, and I Gregorová, and Z Marecek, and F Perlík, and V Kordac
January 1989, Gastroenterology,
V Tesar, and K Horký, and J Jedlicka, and J Petrtýl, and J Kopecká, and I Gregorová, and Z Marecek, and F Perlík, and V Kordac
January 1994, Srpski arhiv za celokupno lekarstvo,
V Tesar, and K Horký, and J Jedlicka, and J Petrtýl, and J Kopecká, and I Gregorová, and Z Marecek, and F Perlík, and V Kordac
December 1992, Gastroenterology,
V Tesar, and K Horký, and J Jedlicka, and J Petrtýl, and J Kopecká, and I Gregorová, and Z Marecek, and F Perlík, and V Kordac
November 1989, Hepatology (Baltimore, Md.),
Copied contents to your clipboard!